Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation

Transplant Infectious Disease

Volumn 17, Issue 1, 2015, Pages 103-105

  Welsch, C ^a,b   Augustin, P ^a,b   Allyn, J ^a,b   Massias, L ^a,b   Montravers, P ^a,b   Allou, N ^a,b  

^a BICHAT HOSPITAL   (France)

^b Univiversité Paris Diderot   (France)

Author keywords

Extracorporeal membrane oxygenation; Imipenem pharmacokinetics; Lung transplantation

Indexed keywords

IMIPENEM; ANTIINFECTIVE AGENT; CREATININE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; ENTEROBACTER CLOACAE; EXTRACORPOREAL OXYGENATION; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; KLEBSIELLA PNEUMONIAE; LIMIT OF QUANTITATION; LUNG FIBROSIS; LUNG LAVAGE; LUNG TRANSPLANTATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS PNEUMONIA; ADVERSE EFFECTS; BLOOD; CROSS INFECTION; MALE; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY;

ANTI-BACTERIAL AGENTS; CREATININE; CROSS INFECTION; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; IMIPENEM; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; TRANSPLANT RECIPIENTS;

EID: 84923224113     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12327     Document Type: Article

References (8)

1. Dudau D, Camous J, Marchand S, et al. Incidence of nosocomial pneumonia and risk of recurrence after antimicrobial therapy in critically ill lung and heart-lung transplant patients. Clin Transplant 2014; 28: 27-36.
2. Joseph J, Rodvold KA. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections. Expert Opin Pharmacother 2008; 9: 561-575.
3. Garcia-Capdevila L, López-Calull C, Arroyo C, et al. Determination of imipenem in plasma by high-performance liquid chromatography for pharmacokinetic studies in patients. J Chromatogr B Biomed Sci App 1997; 692: 127-132.
4. Roberts JA, Paul SK, Akova M, et al. DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 2014; 58: 1072-1083.
5. Li C, Du X, Kuti JL, Nicolau DP. Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 2007; 51: 1725-1730.
6. Shekar K, Roberts JA, Ghassabian S, et al. Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? J Antimicrob Chemother 2013; 68: 726-727.
7. Shekar K, Roberts JA, McDonald CI, et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care 2012; 16: R194.
8. Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009; 37: 840-851.